Drug Information

Drug General Information
Drug ID
D0UM4S
Former ID
DIB010842
Drug Name
ASG-15ME
Drug Type
Antibody
Indication Bladder cancer [ICD9: 188; ICD10:C67] Phase 1 [524474]
Company
Agensys; seattle genetics
Target and Pathway
Target(s) SLIT and NTRK-like family member 6 (SLITRK6) Target Info [551670]
References
Ref 524474ClinicalTrials.gov (NCT01963052) ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer. U.S. National Institutes of Health.
Ref 551670Clinical pipeline report, company report or official report of Seattle Genetics.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.